COMMUNIQUÉS West-GlobeNewswire

Women’s Health Advocates Call on Province of New Brunswick and Premier Higgs to act urgently following the closure announcement of Clinic 554
02/02/2024
OTTAWA, Feb. 02, 2024 (GLOBE NEWSWIRE) -- Following the announcement of the closure of Clinic 554 in Fredericton, the Society of Obstetricians and Gynaecologists of Canada (SOGC) calls on the Province of New Brunswick [...]
Un défenseur de la santé des femmes demande à la province du Nouveau-Brunswick et au premier ministre Higgs d'agir de façon urgente suite à l'annonce de la fermeture de la clinique 554
02/02/2024
OTTAWA, 02 févr. 2024 (GLOBE NEWSWIRE) -- Suite à l'annonce de la fermeture de la Clinique 554 à Fredericton, la Société des obstétriciens et gynécologues du Canada (SOGC) demande à la province du Nouveau-Brunswick et [...]
BioSenic raises €500,000 in private placement of new shares with established new investors
02/02/2024
PRESS RELEASE – REGULATED INFORMATION NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER [...]
BioSenic lève 500 000 euros dans le cadre d'un placement privé d'actions nouvelles auprès de nouveaux investisseurs établis
02/02/2024
COMMUNIQUE DE PRESSE – INFORMATION REGULEE NE PAS PUBLIER, DISTRIBUER OU DIFFUSER, EN TOUT OU EN PARTIE, DIRECTEMENT OU INDIRECTEMENT, AUX ETATS-UNIS, EN AUSTRALIE, AU CANADA, AU JAPON, EN AFRIQUE DU SUD OU DANS TOUTE [...]
Cingulate Announces Pricing of $7.5 Million Public Offering
02/02/2024
KANSAS CITY, Kan., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) (“Cingulate,” the “Company,” “we,” “our” or “us”), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR [...]
Evaxion Biotech fixe le prix de son offre publique à 15 millions de dollars
02/02/2024
COPENHAGUE, Danemark, 02 févr. 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ : EVAX), ci-après « Evaxion » ou la « Société », une société de biotechnologie axée sur la recherche clinique spécialisée dans le [...]
Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Second Quarter and Six-Month Revenue Results
02/02/2024
- Year-over-year unaudited revenue increased 114% for the fiscal second quarter and 337% for the six months ended December 31, 2023 - NEW YORK, Feb. 02, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: [...]
Safety Shot is the Official Recovery Drink for the Largest Events on Football’s Biggest Weekend in Las Vegas: Shaq’s Fun House, Gronk Beach, Sports Illustrated The Party, and Guy Fieri’s Flavortown Tailgate
02/02/2024
On the weekend of February 11 th sports fans and party goers alike will “REVIVE THE NIGHT AND SEIZE THE MORNING” at dedicated Safety Shot bars at Las Vegas’ hottest venues JUPITER, FL, Feb. 02, 2024 (GLOBE NEWSWIRE) -- [...]
Trading by management and close relations of management
02/02/2024
Trading by management and close relations of management In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU [...]
Jasper Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/02/2024
REDWOOD CITY, Calif., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117 [...]
Pixium Vision announces the rejection of the sale plan (plan de cession) by the Court and the conversion of the receivership proceedings into liquidation proceedings
02/02/2024
Pixium Vision announces the rejection of the sale plan ( plan de cession ) by the Court and the conversion of the receivership proceedings into liquidation proceedings Paris, France, February 2, 202 4 – 02:00 p.m. (CET [...]
Pixium Vision annonce le rejet du plan de cession par le Tribunal et la conversion de la procédure de redressement judiciaire en liquidation judiciaire
02/02/2024
Pixium Vision annonce le rejet du plan de cession par le Tribunal et la conversion de la procédure de redressement judiciaire en liquidation judiciaire Paris, France, 2ème février 2024 – 14h00 CET – Pixium Vision SA ( [...]
Vera Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
02/02/2024
BRISBANE, Calif., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients [...]
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
02/02/2024
DALLAS, Feb. 02, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of [...]
GRI Bio Announces Pricing of $5.5 Million Public Offering
02/02/2024
LA JOLLA, CA, Feb. 02, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc . (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the [...]
SAB Biotherapeutics Announces Executive Leadership Change
02/02/2024
SIOUX FALLS, S.D., Feb. 02, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS ), (“SAB” or the “Company”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing [...]
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/02/2024
SAN DIEGO, Feb. 02, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of [...]
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/02/2024
RESEARCH TRIANGLE PARK, N.C., Feb. 02, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted nine newly-hired [...]
Orchard Therapeutics Announces Multiple Presentations at the 20th Annual WORLDSymposium
02/02/2024
Three oral presentations and seven posters highlight transformative potential of HSC gene therapy and newborn screening to address severe neurometabolic diseases BOSTON and LONDON, Feb. 02, 2024 (GLOBE NEWSWIRE) -- [...]

Pages